| |
|
|
|
|
|
|
|
|
1. |
Record Nr. |
UNINA9910700341003321 |
|
|
Autore |
Dodaro Gene L |
|
|
Titolo |
Testimony of Eugene L. Dodaro to be Comptroller General of the United States, U.S. Government Accountability Office [[electronic resource] ] : statement before the Senate Committee on Homeland Security and Governmental Affairs, November 18, 2010 / / [statement of Gene Dodaro] |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
[Washington, D.C.] : , : U.S. Govt. Accountability Office, , [2010] |
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (3 pages) |
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Title from PDF caption title screen (GAO, viewed May 11, 2011). |
"A92918"--List of GAO reports. |
|
|
|
|
|
|
|
|
2. |
Record Nr. |
UNINA9910797350603321 |
|
|
Titolo |
Chinmedomics : the integration of serum pharmacochemistry and metabolomics to elucidate the scientific value of traditional Chinese medicine / / editor, Xijun Wang ; associate editors, Aihua Zhang, Hui Sun |
|
|
|
|
|
|
|
Pubbl/distr/stampa |
|
|
Amsterdam, [Netherlands] : , : Academic Press, , 2015 |
|
©2015 |
|
|
|
|
|
|
|
|
|
ISBN |
|
0-12-803118-2 |
0-12-803117-4 |
|
|
|
|
|
|
|
|
Descrizione fisica |
|
1 online resource (408 p.) |
|
|
|
|
|
|
Disciplina |
|
|
|
|
|
|
Soggetti |
|
Pharmaceutical chemistry |
Medicine - China - Philosophy - History |
Medicine, Oriental - Philosophy - History |
China |
|
|
|
|
|
|
|
|
Lingua di pubblicazione |
|
|
|
|
|
|
Formato |
Materiale a stampa |
|
|
|
|
|
|
|
|
|
|
|
Livello bibliografico |
Monografia |
|
|
|
|
|
Note generali |
|
Description based upon print version of record. |
|
|
|
|
|
|
Nota di bibliografia |
|
Includes bibliographical references at the end of each chapters and index. |
|
|
|
|
|
|
|
|
Nota di contenuto |
|
Cover; Title Page; Copyright Page; Contents; List of Contributors; About the Editor; Preface; Chapter 1 - Origin of Chinmedomics; 1.1 - Introduction; 1.2 - Application and Challenges of TCM; 1.3 - Metabolomics: An Overview; 1.4 - Process of the Serum Pharmacochemistry of TCM; 1.5 - Establishment and Evolution of Chinmedomics; 1.6 - Potential Value of Chinmedomics; 1.7 - Future Perspectives; References; Chapter 2 - Methods and Protocols of Chinmedomics; 2.1 - Introduction; 2.2 - Analytical Technologies; 2.3 - Sampling; 2.4 - Data Extraction and Analysis |
2.5 - Marker Identification and Validation2.6 - Correlation Analysis between Marker Metabolites and Absorbed Chemical Components; 2.7 - Goals for Chinmedomics; 2.7.1 - Biological Mechanisms of the TCM Syndrome; 2.7.2 - Pharmacological Effects of Formulae; 2.7.3 - Correlation Analysis of Formulae and Syndrome for Effective Substances; 2.8 - Chinmedomics for Yinchenhao Tang: A Case Study; 2.9 - Conclusions; References; Chapter 3 - Chinmedomics Advancing Drug Discovery and Development from Yinchenhao Tang; 3.1 - Introduction; 3.2 - Experimental Detail; 3.2.1 - Chemicals and Materials |
3.3.4 - Cell Test to Verify the Therapeutic Efficacy of the Correlated Chemical Components3.4 - Conclusions; Chapter 4 - Chinmedomics Approach Dissects Therapeutic Properties of ShenQiWan Acting on ShenYangXu Syndrome; 4.1 - Introduction; 4.2 - Experimental Detail; 4.2.1 - Chemicals and Materials; 4.2.2 - Metabolomics Study; 4.2.2.1 - Animal Handling; 4.2.2.2 - Sample Collection and Preparation; 4.2.2.3 - UPLC-Q-TOF-HDMS Analysis; 4.2.2.4 - Metabolic Profiling and Metabolite Analysis; 4.2.3 - Constituents Analysis In Vitro and In Vivo; 4.2.3.1 - Animals |
4.2.3.2 - Preparation of SQW Samples for Analysis |
|
|
|
|
|
|
|
| |